News

February 11, 2020
summer 2015

What’s the link between autism and gut bacteria? Gut bacteria may contribute to the development of autism-like behaviors.

A long term study investigating the impact of microbiota therapy on Autism Spectrum Disorder symptoms was completed at the Arizona State University. The treatment protocol included antibiotics, a bowel cleanse, and a high dose of Intestinal Microbiota Transfer. Prior to treatment, 83% of the children were classified as “severe” on the autism spectrum. At the two-year post-treatment follow up, only 17% classified as severe and 44% of the children fell below the Autism Spectrum Disorder diagnostic cut-off point.

read more
February 5, 2020
summer 2015

Because the World Needs Superheroes, These Doctors Work to Advance Medical Research and Save Lives

Achieving Cures Together is honored to be highlighted with Dr. Khoruts and the University of Minnesota's Microbiota Therapeutics Program for our development of encapsulated microbiota.

read more
January 21, 2020
summer 2015

OSU Studies Gut Microbiome Compositions and Links To Children’s Behavior

A study of early school-aged children shows a connection between the bacteria in their gut and their behavior, and that parents play a key role in their kids’ microbiome beyond the food they provide. The analysis showed that children with behavioral problems and higher socioeconomic stress had different microbiome profiles than those who didn’t, and also that the quality of the parent-child relationship, as well as parental stress, played a role in how pronounced those differences were.

read more
December 10, 2019
summer 2015

Altered Gut Microbiota Could Be Therapeutic Target in Rett Syndrome, Study Suggests

The altered gut bacteria found in girls with Rett syndrome influence their gastrointestinal symptoms and disease severity, making the gut microbiota a potential therapeutic target, a review study reports.

read more
November 12, 2019
summer 2015

Researchers project that by 2050, the rate of infections resistant to antibiotics is likely to grow to 40%.

The Council of Canadian Acadamies comprehensive assessment of the current and future impact of antimicrobial resistance (AMR) predicts that the rate of resistance will grow from 26% in 2018 to 40% in 2050. The CCR also analyzes the implications of AMR to public health, the economy, industry & quality of life.

read more
November 4, 2019
summer 2015

A type of gut bacteria may increase risk of bowel cancer

New research presented at the 2019 NCRI Cancer Conference has shown that people with a certain type of bacteria in their guts may be more likely to develop bowel cancer.

read more
October 14, 2019
summer 2015

Gut bacteria can prevent and cure rotavirus infection

The presence of specific microbiota, or microorganisms that live in the digestive tract, can prevent and cure rotavirus infection, which is the leading cause of severe, life-threatening diarrhea in children worldwide, according to a new study by the Institute for Biomedical Sciences at Georgia State University.

read more
October 6, 2019
summer 2015

Congratulations 2019 Robert E. Wilkins Award Winner, Amanda Kabage!

Achieving Cures Together is proud to recognize Amanda Kabage as the 2019 Robert E. Wilkens award winner. This award was created in honor of the late Robert E. Wilkens, who was dedicated in both life and legacy to finding cures and providing healing through Microbiota Therapeutics research. We are honored each year to recognize an outstanding member of the community who is continuing this mission. Amanda has an inspiring story and brings a unique perspective, passion, and determination to her life-saving work every single day. In 2012, Amanda was suffering from an antibiotic resistant superbug, Clostridium difficile. She battled this horrific superbug for 14 months and quickly found herself unable to work, travel, exercise, or participate in things she loved to do. Frustrated by this debilitating superbug and the standard antibiotic treatment cycles, she started researching a novel therapy now known as Intestinal Microbiota Transplant (IMT). In 2013, Amanda was given an IMT by Dr. Khoruts at the University of Minnesota and was healed! Through her direct experience, Amanda changed career paths from pediatric cancer research and joined the University of Minnesota Microbiota Therapeutics team. As an integral member of the team, Amanda helped establish the first stool donor program in the world, has been involved in countless groundbreaking microbiome research studies, and has inspired, given hope, and helped cure many suffering patients. In 2016, Robert Wilkens met Amanda at an Achieving Cures Together meeting. He was very impressed with her and at that moment, knew Amanda was a key player in microbial restoration research. Robert would be extremely proud to know that Amanda carries on his legacy today and Achieving Cures Together is honored to present this award to such a deserving individual.

read more
October 4, 2019
summer 2015

Microbiome Provides New Clues to Determining Development of Colon Cancer

A mutant protein found in humans with colon cancer blocks a pathway that regulates proliferation and expansion of cells, increasing amounts of bacterial species associated with the development of colon cancer. These findings, showcasing the connection between bacteria in the microbiome and colon cancer, were published by a team of researchers from the George Washington University (GW) in the journal Gastroenterology.

read more
September 16, 2019
summer 2015

Pioneering microbiome findings shed light on aspiration

A study at Boston Children's Hospital and the Massachusetts Institute of Technology sheds light on the interactions between the lung and gastrointestinal microbiomes. These findings point to the possibility of one day identifying biomarkers for aspiration based on the presence of certain bacteria in both the lungs and the oropharynx.

read more

Sign up for our Newsletter

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form